Title : The phospholipase A2 inhibitor, quinacrine, reduces infarct size in rats after transient middle cerebral artery occlusion.

Pub. Date : 1997 Mar 28

PMID : 9106458






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The phospholipase A2 inhibitor, quinacrine, reduces infarct size in rats after transient middle cerebral artery occlusion. Quinacrine phospholipase A2 group IB Rattus norvegicus
2 The phospholipase A2 (PLA2) inhibitor, quinacrine (5 mg/kg) or saline (of equal volume), was administered upon reperfusion to rats that underwent 2 h of middle cerebral artery occlusion (MCAO) via the intraluminal filament method. Quinacrine phospholipase A2 group IB Rattus norvegicus
3 The phospholipase A2 (PLA2) inhibitor, quinacrine (5 mg/kg) or saline (of equal volume), was administered upon reperfusion to rats that underwent 2 h of middle cerebral artery occlusion (MCAO) via the intraluminal filament method. Quinacrine phospholipase A2 group IB Rattus norvegicus